Synchronous multiple primary lung cancers with different response to gefitinib
Authors:
- Im Il NaINIm Il Na
- Sung Hyun YangSYSung Hyun Yang
- Jae Soo KohJKJae Soo Koh
- Cheol Hyeon KimCKCheol Hyeon Kim
- Jae Cheol LeeJLJae Cheol Lee
- 1 August 2006
- journal article
- case report
- Published by Elsevier in Lung Cancer
- Vol. 53 (2) , 245-248
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Mutations of the epidermal growth factor receptor in non-small cell lung cancer – Search and destroyEuropean Journal of Cancer, 2006
- Patterns of Allelic Loss of Synchronous Adenocarcinomas of the LungAmerican Journal of Surgical Pathology, 2005
- KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or ErlotinibPLOS Medicine, 2005
- Microsatellite Analysis of Synchronous and Metachronous TumorsDiagnostic Molecular Pathology, 2003
- Special Treatment Issues*Chest, 2003
- Molecular analysis of synchronous and metachronous tumors of the lung: Impact on management and prognosisAnnals of Diagnostic Pathology, 2001
- Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinomaCancer, 1999
- Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutationBritish Journal of Cancer, 1999
- Synchronous and metachronous lung carcinomas: Molecular evidence for multicentricityPathology International, 1998
- Clonal Origin of Multiple Lung CancersDiagnostic Molecular Pathology, 1997